中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2013年
3期
14-15
,共2页
痴呆%血管性%奥拉西坦%茴拉西坦%对比研究
癡呆%血管性%奧拉西坦%茴拉西坦%對比研究
치태%혈관성%오랍서탄%회랍서탄%대비연구
Dementia%Vascular%Olathe Tampa%Hui raschig Tampa%Comparative study
目的对比研究奥拉西坦与茴拉西坦治疗血管性痴呆的临床疗效.方法选择96例血管性痴呆患者,随机分成两组,治疗组(奥拉西坦组)48例,给予奥拉西坦0.4 g,3次/日;对照组(茴拉西坦组)48例,给予茴拉西坦0.2 g,3次/日,两组疗程均为90 d.所有患者均在治疗前和治疗后分别应用MMSE、ADL、NIHSS测评其疗效.对两组患者治疗前后MMSE、ADL、NIHSS评分变化采用t 检验进行分析.结果奥拉西坦组患者MMSE、ADL、NIHSS评分改变显著优于对照组(P <0.05).结论奥拉西坦能改善血管性痴呆患者的认知功能,且疗效优于茴拉西坦,无不良反应.
目的對比研究奧拉西坦與茴拉西坦治療血管性癡呆的臨床療效.方法選擇96例血管性癡呆患者,隨機分成兩組,治療組(奧拉西坦組)48例,給予奧拉西坦0.4 g,3次/日;對照組(茴拉西坦組)48例,給予茴拉西坦0.2 g,3次/日,兩組療程均為90 d.所有患者均在治療前和治療後分彆應用MMSE、ADL、NIHSS測評其療效.對兩組患者治療前後MMSE、ADL、NIHSS評分變化採用t 檢驗進行分析.結果奧拉西坦組患者MMSE、ADL、NIHSS評分改變顯著優于對照組(P <0.05).結論奧拉西坦能改善血管性癡呆患者的認知功能,且療效優于茴拉西坦,無不良反應.
목적대비연구오랍서탄여회랍서탄치료혈관성치태적림상료효.방법선택96례혈관성치태환자,수궤분성량조,치료조(오랍서탄조)48례,급여오랍서탄0.4 g,3차/일;대조조(회랍서탄조)48례,급여회랍서탄0.2 g,3차/일,량조료정균위90 d.소유환자균재치료전화치료후분별응용MMSE、ADL、NIHSS측평기료효.대량조환자치료전후MMSE、ADL、NIHSS평분변화채용t 검험진행분석.결과오랍서탄조환자MMSE、ADL、NIHSS평분개변현저우우대조조(P <0.05).결론오랍서탄능개선혈관성치태환자적인지공능,차료효우우회랍서탄,무불량반응.
Objective To contrast research olathe tanks and Hui raschig jotham the clinical curative effect of the treatment of vascular dementia. Methods Choose 96 cases of vascular dementia patients,randomly divided into two groups,the treatment group(olathe jotham group)48 cases,give olathe jotham 0.4 g,3 times/day,Control group(Hui raschig jotham group)48 cases,give Hui raschig jotham 0.2 g,3 times/day,two groups of treatment are for 90 days. All patients were in before treatment and after treatment were applied MMSE and ADL,NIHSS evaluation its curative effect. The two groups of patients before and after treatment,MMSE ADL,NIHSS score changes were analyzed by t test. Results The tanzi olathe patients MMSE and ADL,NIHSS score change is significantly better than that in control group(P < 0.05). Conclusion Olathe tanks can improve the cognitive function of patients with vascular dementia, and the curative effect is better than the Hui raschig jotham, no bad reaction.